254 related articles for article (PubMed ID: 32071217)
1. Phosphoproteomic analysis of protease-activated receptor-1 biased signaling reveals unique modulators of endothelial barrier function.
Lin Y; Wozniak JM; Grimsey NJ; Girada S; Patwardhan A; Molinar-Inglis O; Smith TH; Lapek JD; Gonzalez DJ; Trejo J
Proc Natl Acad Sci U S A; 2020 Mar; 117(9):5039-5048. PubMed ID: 32071217
[TBL] [Abstract][Full Text] [Related]
2. Phosphoproteomic analysis of thrombin- and p38 MAPK-regulated signaling networks in endothelial cells.
Molinar-Inglis O; Wozniak JM; Grimsey NJ; Orduña-Castillo LB; Cheng N; Lin Y; Gonzalez Ramirez ML; Birch CA; Lapek JD; Gonzalez DJ; Trejo J
J Biol Chem; 2022 Apr; 298(4):101801. PubMed ID: 35257745
[TBL] [Abstract][Full Text] [Related]
3. Occupancy of human EPCR by protein C induces β-arrestin-2 biased PAR1 signaling by both APC and thrombin.
Roy RV; Ardeshirylajimi A; Dinarvand P; Yang L; Rezaie AR
Blood; 2016 Oct; 128(14):1884-1893. PubMed ID: 27561318
[TBL] [Abstract][Full Text] [Related]
4. A novel protein C-factor VII chimera provides new insights into the structural requirements for cytoprotective protease-activated receptor 1 signaling.
Gleeson EM; McDonnell CJ; Soule EE; Willis Fox O; Rushe H; Rehill A; Smith OP; O'Donnell JS; Preston RJS
J Thromb Haemost; 2017 Nov; 15(11):2198-2207. PubMed ID: 28834159
[TBL] [Abstract][Full Text] [Related]
5. Activated protein C promotes protease-activated receptor-1 cytoprotective signaling through β-arrestin and dishevelled-2 scaffolds.
Soh UJ; Trejo J
Proc Natl Acad Sci U S A; 2011 Dec; 108(50):E1372-80. PubMed ID: 22106258
[TBL] [Abstract][Full Text] [Related]
6. Protease-activated receptor-1 cleaved at R46 mediates cytoprotective effects.
Schuepbach RA; Madon J; Ender M; Galli P; Riewald M
J Thromb Haemost; 2012 Aug; 10(8):1675-84. PubMed ID: 22712885
[TBL] [Abstract][Full Text] [Related]
7. FVIIa (Factor VIIa) Induces Biased Cytoprotective Signaling in Mice Through the Cleavage of PAR (Protease-Activated Receptor)-1 at Canonical Arg41 (Arginine41) Site.
Kondreddy V; Pendurthi UR; Xu X; Griffin JH; Rao LVM
Arterioscler Thromb Vasc Biol; 2020 May; 40(5):1275-1288. PubMed ID: 32212848
[TBL] [Abstract][Full Text] [Related]
8. Caveolae are required for protease-selective signaling by protease-activated receptor-1.
Russo A; Soh UJ; Paing MM; Arora P; Trejo J
Proc Natl Acad Sci U S A; 2009 Apr; 106(15):6393-7. PubMed ID: 19332793
[TBL] [Abstract][Full Text] [Related]
9. aPC/PAR1 confers endothelial anti-apoptotic activity via a discrete, β-arrestin-2-mediated SphK1-S1PR1-Akt signaling axis.
Molinar-Inglis O; Birch CA; Nicholas D; Orduña-Castillo L; Cisneros-Aguirre M; Patwardhan A; Chen B; Grimsey NJ; Coronel LJ; Lin H; Gomez Menzies PK; Lawson MA; Patel HH; Trejo J
Proc Natl Acad Sci U S A; 2021 Dec; 118(49):. PubMed ID: 34873055
[TBL] [Abstract][Full Text] [Related]
10. Activated protein C-cleaved protease activated receptor-1 is retained on the endothelial cell surface even in the presence of thrombin.
Schuepbach RA; Feistritzer C; Brass LF; Riewald M
Blood; 2008 Mar; 111(5):2667-73. PubMed ID: 18089851
[TBL] [Abstract][Full Text] [Related]
11. Thrombomodulin Switches Signaling and Protease-Activated Receptor 1 Cleavage Specificity of Thrombin.
Biswas I; Giri H; Panicker SR; Rezaie AR
Arterioscler Thromb Vasc Biol; 2024 Mar; 44(3):603-616. PubMed ID: 38174561
[TBL] [Abstract][Full Text] [Related]
12. Protease-activated receptor-1 signaling by activated protein C in cytokine-perturbed endothelial cells is distinct from thrombin signaling.
Riewald M; Ruf W
J Biol Chem; 2005 May; 280(20):19808-14. PubMed ID: 15769747
[TBL] [Abstract][Full Text] [Related]
13. Biased agonism of protease-activated receptor-1 regulates thromboinflammation in murine sickle cell disease.
Ramadas N; Lowder K; Dutton J; Trebak F; Faes C; Griffin JH; Pawlinski R; Mosnier LO; Sparkenbaugh E
Blood Adv; 2024 Jun; 8(12):3272-3283. PubMed ID: 38640339
[TBL] [Abstract][Full Text] [Related]
14. A New Concept of Action of Hemostatic Proteases on Inflammation, Neurotoxicity, and Tissue Regeneration.
Gorbacheva LR; Kiseleva EV; Savinkova IG; Strukova SM
Biochemistry (Mosc); 2017 Jul; 82(7):778-790. PubMed ID: 28918742
[TBL] [Abstract][Full Text] [Related]
15. Protection of vascular barrier integrity by activated protein C in murine models depends on protease-activated receptor-1.
Schuepbach RA; Feistritzer C; Fernández JA; Griffin JH; Riewald M
Thromb Haemost; 2009 Apr; 101(4):724-33. PubMed ID: 19350118
[TBL] [Abstract][Full Text] [Related]
16. Paradigm of Biased PAR1 (Protease-Activated Receptor-1) Activation and Inhibition in Endothelial Cells Dissected by Phosphoproteomics.
van den Eshof BL; Hoogendijk AJ; Simpson PJ; van Alphen FPJ; Zanivan S; Mertens K; Meijer AB; van den Biggelaar M
Arterioscler Thromb Vasc Biol; 2017 Oct; 37(10):1891-1902. PubMed ID: 28818855
[TBL] [Abstract][Full Text] [Related]
17. The ligand occupancy of endothelial protein C receptor switches the protease-activated receptor 1-dependent signaling specificity of thrombin from a permeability-enhancing to a barrier-protective response in endothelial cells.
Bae JS; Yang L; Manithody C; Rezaie AR
Blood; 2007 Dec; 110(12):3909-16. PubMed ID: 17823308
[TBL] [Abstract][Full Text] [Related]
18. Biased agonism of protease-activated receptor 1 by activated protein C caused by noncanonical cleavage at Arg46.
Mosnier LO; Sinha RK; Burnier L; Bouwens EA; Griffin JH
Blood; 2012 Dec; 120(26):5237-46. PubMed ID: 23149848
[TBL] [Abstract][Full Text] [Related]
19. Integration of endothelial protease-activated receptor-1 inflammatory signaling by ubiquitin.
Grimsey NJ; Trejo J
Curr Opin Hematol; 2016 May; 23(3):274-9. PubMed ID: 26845544
[TBL] [Abstract][Full Text] [Related]
20. An siRNA library screen identifies CYLD and USP34 as deubiquitinases that regulate GPCR-p38 MAPK signaling and distinct inflammatory responses.
Cheng N; Trejo J
J Biol Chem; 2023 Dec; 299(12):105370. PubMed ID: 37865315
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
